Literature DB >> 21429950

Associated factors with antipsychotic use in assisted living facilities: a cross-sectional study of 4367 residents.

Agnes Larrayadieu1, Gabor Abellan van Kan, Antoine Piau, Maria Soto Martin, Fati Nourhashemi, Yves Rolland, Bruno Vellas.   

Abstract

BACKGROUND: antipsychotics are widely used in assisted living (AL facilities). Even more, the prescription of these drugs is gradually increasing since the availability of second-generation atypical antipsychotics. More knowledge is needed on prescription reasons to understand this increasing prevalence.
METHODS: cross-sectional analysis of 4,367 residents. Data were obtained from medical records assessed by geriatricians from the AL facility. A multiple logistic regression model (backward stepwise) was used to assess the independent associated factors with antipsychotic use.
RESULTS: antipsychotic prescription was found in 1,203 (27.5%) of 4,367 residents. The independent associated factors with the use of antipsychotics were the presence of a psychiatric disorder [odds ratio, OR = 5.30 (4.42-6.35)], the age under 80 years [OR = 2.08 (1.62-2.68)], admission from another institution [OR = 1.49 (1.12-1.98)], treated dementia [OR = 1.84 (1.47-2.30)], the presence of neuropsychiatric symptoms (NPS): verbal outbursts [OR = 2.58 (1.96-3.39)], threatening behaviours or physical violence [OR = 2.13 (1.71-2.65)], and aimless wandering [OR = 1.55 (1.17-2.04)], the presence of cardiovascular disease [OR = 0.79 (0.65-0.96)] and the presence of cerebrovascular disease [OR = 0.77 (0.64-0.92)].
CONCLUSIONS: the study found that more than a quarter of the residents received antipsychotics. This study also highlighted the independent associated factors with antipsychotic prescription showing 'off-label' prescriptions in conditions such as dementia and certain NPS. The study findings suggest that improvements in the management of dementia and NPS in AL facilities are needed. Non-pharmacological alternatives should be enhanced and further developed viewing the high prevalence of antipsychotic prescription.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429950     DOI: 10.1093/ageing/afr032

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  6 in total

Review 1.  Off-label prescribing in older patients.

Authors:  Stephen H D Jackson; Paul A F Jansen; Arduino A Mangoni
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 2.  Antipsychotic Use in Dementia.

Authors:  Julia Kirkham; Chelsea Sherman; Clive Velkers; Colleen Maxwell; Sudeep Gill; Paula Rochon; Dallas Seitz
Journal:  Can J Psychiatry       Date:  2016-10-08       Impact factor: 4.356

3.  Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing.

Authors:  Graham McIlroy; Sarah K Thomas; Jamie J Coleman
Journal:  J Public Health (Oxf)       Date:  2014-03-28       Impact factor: 2.341

4.  Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada.

Authors:  Kathryn J Stock; Joseph E Amuah; Kate L Lapane; David B Hogan; Colleen J Maxwell
Journal:  Drugs Aging       Date:  2017-01       Impact factor: 3.923

5.  Patterns of prescription of antipsychotics in Qatar.

Authors:  Sami Ouanes; Imen Becetti; Suhaila Ghuloum; Samer Hammoudeh; Mena Shehata; Hany Ghabrash; Areej Yehya; Hawra Al-Lawati; Nora Al-Fakhri; Huma Iram; Nighat Ajmal; Yassin Eltorki; Hassen Al-Amin
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

Review 6.  Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.

Authors:  Dallas P Seitz; Sudeep S Gill; Nathan Herrmann; Sarah Brisbin; Mark J Rapoport; Jenna Rines; Kimberley Wilson; Ken Le Clair; David K Conn
Journal:  Int Psychogeriatr       Date:  2012-10-19       Impact factor: 3.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.